Companies: 10,795·Total market cap: $144.5T

Kadimastem Ltd

Kadimastem Ltd

KMSTFOTCHealthcare

$3.21

$-0.10(-3.02%)

Market Cap$9503988

P/E Ratio—

52W High$9.07082

52W Low$0.6404

Avg Volume40K

Open$3.30

Beta0.57

Net Income Financials Revenue

Kadimastem Ltd (KMSTF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

KMSTF · net income · updated Jun 9, 2026

Core profitability metrics

KMSTF · net income · margin · TTM · CAGR

Net income was −$26.5M for FY2024 (fiscal year ending 2024-12-31), down 119.9% year-over-year. Net profit margin was —.

FY2024 Net Income−$26.5M▼ -119.9% YoY

Trailing 12M (TTM)—trailing 4 quarters sum

Net Profit Margin——

YoY Change-119.9%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · KMSTF net income history · KMSTF profit margin

Annual net income data

KMSTF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2024Loss−$26.5M▼ 119.9%—$0

FY2023Loss−$12.0M▲ +47.0%—$0

FY2022Loss−$22.7M▲ +13.5%—$0

FY2021Loss−$26.3M▼ 21.0%—$0

FY2020Loss−$21.7M▲ +13.5%—$0

Net income vs peers (Healthcare)

KMSTF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Kadimastem Ltd (KMSTF) reported net income of −$26.5M for FY2024 (fiscal year ending 2024-12-31), down 119.9% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Kadimastem Ltd has not yet achieved annual profitability based on available data (13 fiscal years). The company has reported net losses across all available periods.

Kadimastem Ltd's net profit margin was — for FY2024, based on the latest annual results.

Investors sometimes search for "Kadimastem Ltd net worth" — the company's market capitalization is a separate figure from KMSTF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

KMSTF net income · 4 questions

Kadimastem Ltd is not currently profitable on an annual basis. The company reported a net loss of $26.5M for FY2024.

is KMSTF profitabledoes KMSTF make a profitKMSTF profitabilityKMSTF profitable company

▸ Source: FMP /income-statement · GAAP · Kadimastem Ltd · Kadimastem Ltd SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026